← All stocks

Aptevo Therapeutics Inc.

APVO Net buying
CIK 0001671584 #5433 in the set updated 21 Sep 2026
Bought (120 mo)
$25.40M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$17.16M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$17.16M
18 of 18 sales
Net
+$8.24M
+$8.24M against sales at will

By person

17 insiders · 58 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
TANG KEVIN
Exit Filing
$24.85M (16)
$16.87M (17)
+$7.98M
1,760,000
$2.62M
−15.5%
El-Hibri Fuad
Director
$248.19K (10)
+$248.19K
4,066,111
$6.06M
+11.7%
White Marvin L
Executive Chair
$99.90K (4)
$293.00K (1)
−$193.10K
1,261
$1.88K
Maddux Randy Joe
SVP of Operations, CMO
$114.45K (4)
+$114.45K
75,000
$111.75K
Harsanyi Zsolt
Director
$39.00K (1)
+$39.00K
400
$596.00
Grant Grady III
Director
$28.10K (2)
+$28.10K
1,150
$1.71K
Abdun-Nabi Daniel
Director
$15.00K (1)
+$15.00K
400
$596.00
Kunz Barbara Lopez
Director
$8.48K (1)
+$8.48K
400
$596.00
Niederhuber John
Director
$649.74 (1)
+$649.74
400
$596.00
Stromatt Scott C
Chief Medical Officer and SVP
216,183
$322.11K
+9,534%
Gross Jane A
SVP & Chief Scientific Officer
109,583
$163.28K
+3,134%
Mitchell Shawnte
SVP, GC and Corporate Affairs
80,527
$119.99K
+8.1%
Adelman Michael
SVP, Commercial Operations
70,426
$104.93K
+7.5%
Lamothe Jeffrey G.
President and CEO
967
$1.44K
Taylor Daphne
SVP, CFO
638
$950.62
Kwon SoYoung
SVP, GC, BD & Corp Affairs
638
$950.62
Huebner Dirk
SVP, CMO
482
$718.18

No percentages here. This company's share count has moved by a factor of 15.7 over the window, from 1,181,725 to 18,512,084 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
160,000
$9.60
$1.54M
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
200,000
$10.07
$2.01M
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
50,889
$10.43
$530.67K
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
149,111
$11.19
$1.67M
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
75,491
$11.74
$886.43K
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
124,509
$12.45
$1.55M
TANG KEVIN
23 Nov 2021
Exit Filing
Sell indirect
161,336
$13.52
$2.18M
TANG KEVIN
22 Nov 2021
10% owner
Sell indirect
38,664
$6.55
$253.37K
TANG KEVIN
22 Nov 2021
10% owner
Sell indirect
3,719
$6.66
$24.78K
TANG KEVIN
22 Nov 2021
10% owner
Sell indirect
196,281
$7.11
$1.40M
TANG KEVIN
22 Nov 2021
10% owner
Sell indirect
16,667
$7.36
$122.65K
TANG KEVIN
19 Nov 2021
10% owner
Sell indirect
183,333
$7.52
$1.38M
TANG KEVIN
19 Nov 2021
10% owner
Sell indirect
30,467
$8.01
$244.11K
TANG KEVIN
18 Nov 2021
10% owner
Sell indirect
169,533
$8.09
$1.37M
TANG KEVIN
18 Nov 2021
10% owner
Sell indirect
4,023
$8.00
$32.19K
TANG KEVIN
18 Nov 2021
10% owner
Sell indirect
152,764
$8.32
$1.27M
TANG KEVIN
18 Nov 2021
10% owner
Sell indirect
43,213
$9.38
$405.53K
White Marvin L
19 Mar 2018
President and CEO
Sell
100,000
$2.93
$293.00K

What was left out

Form 4 filings counted 223
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 944,340
Sales filed before the plan box existed 18
History held since 27 Sep 2016